(6S,8R)-1-Chloro-8-(3-naphthalen-2-yl-propyl)-4-oxo-3-(3-trifluoromethyl-benzylamino)-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid ethyl ester | 550375-69-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (6S,8R)-1-Chloro-8-(3-naphthalen-2-yl-propyl)-4-oxo-3-(3-trifluoromethyl-benzylamino)-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid ethyl ester
• CAS: 550375-69-4
• 化学式: C₃₁H₂₉ClF₃N₃O₃
• 分子量: 584.038
• InChiKey: VPXZHVXLZOSQFU-NOZRDPDXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.3
• 重原子数：
  41.0
• 可旋转键数：
  9.0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  73.22
• 氢给体数：
  1.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  (6S,8R)-1-Chloro-8-(3-naphthalen-2-yl-propyl)-4-oxo-3-(3-trifluoromethyl-benzylamino)-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid ethyl ester 在 lithium hydroxide 作用下， 以 四氢呋喃 为溶剂， 生成 (6S,8R)-1-Chloro-8-(3-naphthalen-2-yl-propyl)-4-oxo-3-(3-trifluoromethyl-benzylamino)-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid
  参考文献：
  名称：

  Design and Synthesis of Potent, Non-peptide Inhibitors of HCV NS3 Protease

  摘要：

  Starting from a hexapeptide boronic acid lead, 3-amino bicyclic pyrazinones as novel beta-sheet dipeptide mimetics have been designed and synthesized. Side-chain manipulation of this scaffold generated a series of potent, nonpeptidic inhibitors of HCV NS3 protease. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00032-5
• 作为产物：
  描述：

  (2S,4R)-5-Cyano-4-(3-naphthalen-2-yl-propyl)-pyrrolidine-2-carboxylic acid ethyl ester 以 乙酸乙酯 、 甲苯 为溶剂， 生成 (6S,8R)-1-Chloro-8-(3-naphthalen-2-yl-propyl)-4-oxo-3-(3-trifluoromethyl-benzylamino)-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid ethyl ester
  参考文献：
  名称：

  Design and Synthesis of Potent, Non-peptide Inhibitors of HCV NS3 Protease

  摘要：

  Starting from a hexapeptide boronic acid lead, 3-amino bicyclic pyrazinones as novel beta-sheet dipeptide mimetics have been designed and synthesized. Side-chain manipulation of this scaffold generated a series of potent, nonpeptidic inhibitors of HCV NS3 protease. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00032-5